ACHROMYCIN V (tetracycline hydrochloride)
ACHROMYCIN V is indicated for the treatment of Upper Respiratory Tract Infection; Lower Respiratory Tract Infection; Skin and Soft Tissue Infection; Rickettsial Infection; Rocky Mountain Spotted Fever; Typhus; Q Fever; Rickettsialpox; Psittacosis.
Details
- Status
- Discontinued
- First Approved
- 1955-01-27
- Routes
- ORAL
- Dosage Forms
- SUSPENSION, CAPSULE
ACHROMYCIN V Approval History
What ACHROMYCIN V Treats
9 indicationsACHROMYCIN V is approved for 9 conditions since its original approval in 1955. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Upper Respiratory Tract Infection
- Lower Respiratory Tract Infection
- Skin and Soft Tissue Infection
- Rickettsial Infection
- Rocky Mountain Spotted Fever
- Typhus
- Q Fever
- Rickettsialpox
ACHROMYCIN V Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to ACHROMYCIN V
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ACHROMYCIN V FDA Label Details
Indications & Usage
FDA Label (PDF)ACHROMYCIN V is indicated for the treatment of Upper Respiratory Tract Infection; Lower Respiratory Tract Infection; Skin and Soft Tissue Infection; Rickettsial Infection; Rocky Mountain Spotted Fever; Typhus; Q Fever; Rickettsialpox; Psittacosis.
Track ACHROMYCIN V with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.